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EFFECTS OF BETA-ALANINE SUPPLEMENTATION AND HIGH INTENSITY
INTERVAL TRAINING AMONG RECREATIONALLY ACTIVE FEMALES
by
MARY ELIZABETH YARBROUGH
(Under the direction of John Dobson)

ABSTRACT
Beta-alanine is a non-essential amino acid that when combined with L-histidine forms the
dipeptide carnosine. Recent research has shown that supplementary intake of beta-alanine can
substantially increase carnosine content in muscle fibers and has been associated with attenuating
fatigue and enhancing high intensity exercise performance. The aim of this study was to
examine the effects of 4 weeks of beta-alanine supplementation combined with high intensity
interval training (HIIT) on indices of aerobic and anaerobic performance, rowing performance,
and body composition. Twenty-one recreationally active females (22.2 ± 2.2 yrs.) participated in
a double blind, placebo controlled study and were randomly assigned to one of 3 groups: betaalanine (BA, n = 8), placebo (PLA, n = 7), or control (CON, n = 6). Prior to and following 4
weeks of supplementation all groups had anthropometric measurements done and body
composition was determined using dual energy x-ray absorptiometry (DEXA). Participants also
performed a graded exercise test on the rowing ergometer to determine VO2 peak, ventilatory
threshold (VT), and time to exhaustion (TTE). Additionally, participants came back to the lab to
complete a 1,000 m time trial (TT) to determine time for completion and peak power output
(PPO). During the 4 week intervention the BA and PLA groups completed a 7 minute 1: 1
(work: recovery) HIIT protocol that was a pre-determined workload whilst consuming either 6.4
g/day of BA or PLA. All three groups showed significant improvements from pre to post testing
in VO2 peak, TTE, VT, TT, PPO and a reduction in total BF% in arms (p ≤ 0.05). While several
of the variables had significant interactions between groups: VO2 peak, TTE, TT, PPO, BF%
legs, and BF% trunk, (p ≤ 0.05), post hoc testing revealed that peak power output was the only
the variable that showed a significant difference between the BA and PLA groups as compared
to the CON group during post testing (p = 0.00). The results of this study suggest that HIIT can
enhance measures of aerobic capacity and increase PPO, while beta-alanine supplementation did
not seem to have much of an effect on training.
INDEX WORDS: Carnosine, Beta-alanine, Rowing, Time trial, Peak power output, Aerobic capacity,
Ventilatory threshold
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CHAPTER I
INTRODUCTION

Rowing is a full body workout and when rowers are completing a 2,000 meter race in ~68 minutes and is dependent on the capacity of both the aerobic and anaerobic energy pathways.
Some training strategies might involve ergogenic aids such as high intensity interval training or
supplementing with beta-alanine. Beta-alanine has been shown to increase muscle carnosine
content and muscle buffering capacity, while high intensity interval training has been shown to
improve anaerobic and aerobic fitness.
Beta-alanine (BA) is a nonessential amino acid that can combine with L-histidine to form
the cytoplasmic dipeptide carnosine (β-alanyl-L-histidine). In humans, the rate of carnosine
synthesis in skeletal muscle is limited by the availability of beta-alanine. Carnosine is found at
highest concentrations in skeletal muscle and can act as an intracellular buffer during high
intensity exercise, the mechanism of carnosine presumably relates to its characteristics as a
calcium sensitizer (Dutka et al., 2011). There are several determinants of muscle carnosine
concentrations including: gender, age, muscle fiber type, diet, supplementation, and exercise
training (Sale, 2013). According to Dutka and colleagues (2011), carnosine concentrations in
skeletal muscle are almost twice as high in fast-twitch (type II) fibers as slow twitch (type I)
fibers. Harris and colleagues (2006) found that oral supplementation of beta-alanine can
considerably elevate carnosine concentration in humans. The increases in carnosine
concentration within the muscle are associated with performance enhancements, such as
buffering capacity, increased power, and delay in time to fatigue. Several studies have shown
that beta-alanine supplementation can increase muscle carnosine ~45-60% after 4 weeks of
supplementation and can improve anaerobic capacity and muscle function during high intensity
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exercise (Harris et al., 2006; Derave et al., 2007). Increases in carnosine concentration through
regular supplementation with beta-alanine may improve muscle buffering capacity and delay the
onset of fatigue during intense exercise (Walter, 2010). Currently, the only known adverse
effects of beta-alanine supplementation are the symptoms of parasthesia, which are triggered by
high and acute single doses and typically disappear within approximately an hour after ingestion
(Harris, 2006). Parasthesia is defined as a skin sensation, such as burning, prickling, itching, or
tingling, with no apparent physical cause. Considering that beta-alanine is an amino acid that
naturally plays a relevant role in the human body and that doses studied so far are quite similar to
that found in diet, it is likely that this supplement is safe (Artioli, 2010). Based off of previous
studies, supplementing with beta-alanine for four or more weeks can evoke significant changes
in exercise performance or capacity especially during high intensity exercise or when
performance is likely to be limited by hydrogen ions in skeletal muscle (Sale, 2013).
High-intensity interval exercise results in diminished stores of adenosine tri-phosphate
(ATP), phosphocreatine (PCr) and glycogenic substrates, and the intracellular accumulation of
metabolites (adenosine di-phosphate (ADP), inorganic phosphate (Pi), hydrogen ions (H+) and
magnesium (Mg+), each of which has been implicated as a cause of muscle fatigue (Smith et al.,
2009). Depletion of PCr store has frequently been cited as a rate limiting factor for performance
of repeated sprint exercises (Bishop, 2004). Different aerobic and anaerobic training modalities
have been shown to enhance performance, including 5- to 30-second repeated sprints
(Burgomaster, 2006 and Creer, 2004). Recent literature has termed this type of training, highintensity interval training (HIIT). HIIT is also known to be a more efficient training strategy for
individuals who have time constraints and want to see similar outcomes to those who do a
traditional endurance training protocol. According to the National Strength and Conditioning
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Association, HIIT training can provide benefits such as: aerobic and anaerobic fitness, decreased
blood pressure, cardiovascular health, insulin sensitivity (which helps the exercising muscles
more readily use glucose for fuel to make energy), lowered cholesterol, lower abdominal fat and
body weight while maintaining muscle mass.
Events such as rowing involve both the anaerobic and aerobic energy systems. Aerobic
oxidation takes over after about 75 seconds of near maximal efforts and becomes the primary
energy system used; it also has the greatest potential for improvement with training, about 2-4%
in well trained athletes (Laursen, 2010) and more in untrained individuals. Akca and Aras
(2015) found that competitive rowers had significantly improved rowing performance (peak
power output, VO2 Peak, and 2,000 meter time to completion) after 4 weeks of high intensity
interval training or supramaximal interval training.
The combination of high intensity interval training and beta-alanine supplementation has
been shown to improve ventilatory threshold (VT), this has been highly correlated with lactate
threshold (LT). While these represent different metabolic mechanisms they are both
representative of anaerobic threshold (AT) (Bishop, 2004). Anaerobic threshold can be defined
as the exercise intensity at which performance decrements rapidly ensue and are considered the
onset of fatigue (Walter, 2010).
There is a dearth of scientific research that involves recreationally active females,
especially using the rowing ergometer as a mode, current research uses the cycle ergometer or
treadmill and to our knowledge there is no current research that specifically looks at BA
supplementation combined with HIIT using non-competitive female rowers. Therefore, the main
purpose of this study was to determine if beta-alanine supplementation combined with four
weeks of high intensity interval training on the rowing ergometer would lead to significant
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improvements in oxygen consumption (VO2peak), ventilatory threshold, and body fat percentage
in recreationally active females. A secondary purpose of this study was to look at time to
complete a 1,000 meter time trial and peak power output in pre and post testing as well as
segmental body composition changes in the arms, trunk, and legs. It was hypothesized that
supplementing with beta-alanine and HIIT for 28 days would lead to improvements in VO2 peak,
ventilatory threshold, body composition, 1,000 meter time trial, and peak power.
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CHAPTER II
REVIEW OF LITERATURE
Most research using the rowing ergometer involves competitive rowers, as this mode can
provide a full body workout while using both anaerobic and aerobic energy pathways. High
intensity interval training (HIIT) has become popular for people who have time constraints, but
want the benefits of endurance training, improvements in oxygen consumption and time to
exhaustion (NSCA). Beta-alanine supplementation has been shown to help with pH buffering in
skeletal muscle and can attenuate muscular fatigue. Combinations of HIIT and BA
supplementation on the rowing ergometer could potentially delay the onset of fatigue, increase
peak power, increase oxygen consumption, and improve time trial performance, while providing
a full body workout.
Beta-alanine and Carnosine
Carnosine (β-alanyl-L-hisitdine) is a cytoplasmic dipeptide that is synthesized from betaalanine and histidine; it is found in the highest concentration in skeletal muscle and relatively
high concentrations within the central nervous system (Sale, 2013). Carnosine contributes to
intracellular muscle pH buffering capacity and among other functions is thought to play a role in
slowing the development of acidotic muscle fatigue (Decombaz, 2011; Artioli, 2010; and
Derave, 2007). Oral ingestion of beta-alanine (3.2-6.4g/day), the rate limiting precursor in
carnosine synthesis, has been shown to elevate the muscle carnosine content by ~45-60% after 4
weeks of supplementation with an aim to improve anaerobic muscle capacity and muscle
function during high intensity exercise (Harris, 2006 and Derave, 2007). The endogenous
formation of beta-alanine in humans is synthesized in the liver from degradation of uracil, where
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exogenous supply mostly depends on the type and amount of animal protein in the diet
(Decombaz, 2011). On average an omnivore can ingest ~ 0.8 g/day of carnosine from meat and
fish (Harris, 2006) with the highest concentrations found in chicken and turkey (Abe, 2000).
Harris and colleagues (2006) tested three different doses: 40, 20, and 10 mg/per kg of
body weight/per day. They found that the highest dose elicited a peak in serum beta-alanine
levels, which was related to intense and unpleasant symptoms of paresthesia starting
approximately 20 minutes after the capsule ingestion and ending approximately 60 minutes after.
Parasthesia is defined as a skin sensation, such as burning, prickling, itching, or tingling, with no
apparent physical cause and could potentially cause unpleasant sensory symptoms associated
with the ingestion of beta-alanine. The 20 mg dose resulted in a lower peak in serum betaalanine, but was also accompanied by symptoms of paresthesia, which were less frequent and
intense, while the 10 mg/per kg of body weight resulted in no significant symptoms of
paresthesia and a discrete peak of serum beta-alanine. Harris et al. (2006) split the amounts of
beta-alanine given daily into multiple doses of 800 mg (~10 mg/kg/day) and was successful in
reducing the incidence of paresthesia. Numerous studies have also confirmed the efficacy of this
supplementation protocol, (Hill, 2007 and Kendrick, 2008), and more recently, data suggest that
it is possible to reach the same total daily dose of 6.4 g using a twofold higher single dose when
using controlled release capsules (1600 mg instead of 800 mg) (Hoffman, 2008, Stout, 2007, and
Zoeller, 2007).
Decombaz et al. (2011) compared the kinetics of plasma beta-alanine and its association
with beta-alanine induced paresthesia symptoms following the ingestion of 1.6 g/day of betaalanine slow release tablets or the pure aqueous solution of beta-alanine. Three different
treatments were administered: 1.6g of pure beta-alanine in an aqueous solution, 1.6 g of slow
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release beta-alanine, or placebo (Carnosyn™, Natural Alternatives International (NAI), San
Marcos CA) each was ingested with 250 ml of water. Each treatment was separated by one week
and in a fasted state. Subjects were provided with questionnaires with information on sensations,
mood, or anxiety state and blood and urine samples were collected at various intervals to assess
beta-alanine concentrations over the course of the next 6 hours. Researchers found that ingesting
slow release tablets, rather than the pure solution, improved retention of carnosine and there was
no evidence of paresthesia in either group.
Stegen and colleagues (2014) designed an experiment to determine an optimal
maintenance dose ensuring that carnosine levels remained elevated by 30-50% above baseline.
They wanted to determine if sex, body mass, and fat free mass are factors during muscle
carnosine loading, maintenance, and washout. The researchers found that sex and body mass
have minimal effects on absolute carnosine increases and are not the major determinants for
increases in carnosine content. In order to keep levels ~30-50% above baseline, an average dose
of 1.2 g/day is considered optimal to maintain carnosine concentration. The washout period for
beta-alanine appears to be a relatively slow process ~2-4% a week, but is also related to the
carnosine content; essentially, the more you have, the more you can lose (Stegen, 2014; Baguet,
2009; and Stellingwerff, 2011). Moreover, Baguet and colleagues (2009) showed that there are
high and low responders to beta-alanine supplementation. The washout period for high
responders is about 15 weeks compared to 6 for low responders, this after supplementing with
4.8 g/day for 6 weeks (Baguet et al., 2009). Evidence seems to indicate that taking beta-alanine
is safe is doses from 3.2-6.4 g/day and that the slow release tablets can help reduce the incidence
of any unpleasant side effects.
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Beta-alanine and Performance
Several researchers have used the non-invasive method called proton magnetic resonance
spectroscopy (MRS) to assess carnosine concentrations in skeletal muscle and have determined
that it is an effective and practical tool that can be used to assess muscle carnosine content as
opposed to muscle biopsies (Bex, 2013 and Derave, 2007). Bex and colleagues (2013) also
wanted to determine if carnosine concentrations were higher in trained rather than untrained
individuals. The study found that the carnosine levels were much higher (almost double) after
supplementation as compared to the untrained individuals (Bex et al, 2013) which is comparable
to other studies (Baguet et al., 2010; Derave,et al., 2007; and Saunders, 2012). In contrast
Painelli and colleagues (2014) found that beta-alanine, when used an ergogenic aid for highintensity exercise, can improve exercise performance regardless of training status. In a similar
study Derave and colleagues (2007) aimed to evaluate the use of proton MRS as a non-invasive
tool to monitor carnosine concentrations and to determine if supplementation with beta-alanine
for 4 weeks would elevate muscle carnosine and affect exercise performance in 400 m sprint
among trained athletes. The beta-alanine group significantly increased carnosine content and
dynamic knee extension torque significantly improved as compared to the placebo group.
Despite conflicting results it would appear that in certain situations beta-alanine can augment
carnosine content in trained individuals more than in the untrained.
Jordan and colleagues (2010) were the first researchers to look at running performance
and the onset of blood lactate accumulation (OBLA) during a graded exercise test (GXT) after
supplementation with beta-alanine. The beta-alanine group did have a delay in the onset of
OBLA after 4 weeks of supplementation, but also had a reduced aerobic capacity in comparison
to the placebo group. Other research has shown that supplementing with beta-alanine can also
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reduce the onset of blood lactate accumulation (OBLA) by increases in heart rate at OBLA, %
heart rate max @ OBLA as compared to the placebo groups (Jordan, 2010 and Zoeller, 2007).
Both studies also showed no changes in VO2 peak or decrements with the beta-alanine, these
were similar to other findings (Stout, 2006; Baguet, 2010; and Kresta, 2014). Other studies have
shown that supplementing with beta-alanine, sodium bicarbonate, or the combination of the two
can increase blood lactate levels during exercise (Tobias et al., 2013 and Mero et al., 2013).
Saunders and colleagues (2012a) found that both the placebo and beta-alanine groups had
increased blood lactate levels during exercise with no effects from supplementation. This is
similar to what Baguet et al. (2010) found in a comparable study. While blood lactate levels
increase during exercise, the reduction of OBLA improved after supplementing with betaalanine, sodium bicarbonate, or the combination of the two. VO2 peak did not significantly
improve in the groups, however time to exhaustion did improve. This delayed onset of
neuromuscular fatigue was most likely due to the increased carnosine concentration.
Stout et al. (2006) examined the effects of 28 days of beta-alanine supplementation and
the onset of neuromuscular fatigue and ventilatory threshold among women. The researchers
found that the ventilatory threshold (VT) improved, physical working capacity increased, and
time to exhaustion all improved in the beta-alanine group as compared to the placebo group.
They did not see any significant improvements in maximal oxygen consumption. In contrast
Smith and colleagues (2012) found that both the beta-alanine and placebo groups had significant
improvements in maximal oxygen consumption and slight, non-significant changes in time to
exhaustion and ventilatory threshold. Kresta et al. (2014) researchers had recreationally active
females supplement with creatine and beta-alanine combined, beta-alanine, creatine, or placebo.
They found that there were not any significant improvements on body composition, aerobic (VO2
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peak, TTE, or VT), or anaerobic performance (total work or peak power) measures in any of the
groups.
Hoffman and colleagues (2014) wanted to determine if supplementation with beta-alanine
could improve tactical and cognitive performance among an elite combat unit after a series of
exhaustive exercises. The researchers found that cognitive performance was not impacted, but
power performance, marksmanship, and target engagement speed improved from pre-ingestion
levels. Both the placebo and beta-alanine groups had significant improvements in their 4km run
time, but no difference between groups. Peak jump power and number of firing shots at post
testing was greater for the participants who consumed beta-alanine as compared to the placebo
group.
Painelli et al. (2014) looked at the effects of training status on high intensity intermittent
performance after supplementing with beta-alanine. The trained (T) and non-trained (NT) men
were split between placebo (PL) and beta-alanine (BA), this provided four experimental
conditions total. Researchers found that total work done significantly increased following
supplementation in both the TBA and NTBA groups, significantly decreased in the NTPL, and
had no change in the TPL. Regardless of training status researchers determined that using betaalanine as an ergogenic aid for high intensity exercise can be beneficial. These findings are in
contrast to previous studies that have shown no effect of beta-alanine supplementation with
highly trained individuals (Derave et al. 2007; Baguet et al 2010; and Saunders et al 2012).
Baguet and colleagues (2010) looked at the role of muscle carnosine in rowing
performance and found that there was a positive correlation between the two. The beta-alanine
group also improved time to exhaustion following supplementation by 4.3 seconds as compared
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to the placebo group. Ducker et al. (2013) found that 2,000 meter rowing performance did
improve after 28 days of beta-alanine supplementation in well trained rowers, however this only
had a significance level of (p < 0.055) and was not supported by moderate to large effect size
(Ducker, 2013). While both of these studies showed improvements in performance, it should be
noted that they both had small sample sizes and both had p- values that were near significance.
During intense anaerobic exercises, one of the major causes of fatigue is believed to be
acidosis caused by the accumulation of hydrogen ions [H+], this corresponds to the decrease of
the pH in blood. Along with carnosine being used as a pH buffering agent is sodium
bicarbonate, which can also be used as an ergogenic aid. Tobias et al. (2013) had well-trained,
experienced judo and jiu-jitsu male competitors complete the study. They were randomly
assigned to the placebo (PL+PL), beta-alanine + placebo (BA+PL), placebo + sodium
bicarbonate (SB+PL), or beta-alanine + sodium bicarbonate (BA+SB) group. Both BA+PL and
SB+PL had gains in the total work done, peak power, and post exercise blood lactate. The group
that had co-ingestion (BA+SB) had a significant effect on total work done, peak power, post
exercise blood lactate, and ratings of perceived exertion (RPE). Researchers concluded that
while sodium bicarbonate and beta-alanine and can elicit improvements in aerobic and anaerobic
measures the two combined can significantly lead to greater improvements in performance and
RPE. Furthermore, taking the two in combination enhances it’s effects as a buffering agent
during intense exercise.
Several studies have also investigated the effects of beta-alanine supplementation on
body composition (Glenn et al., 2015; Kresta et al., 2014; Kern et al., 2011, and Outlaw et al.,
2014). Glenn and colleagues (2015) looked at total body fat percentage as well as regional areas
of interest and found that after supplementing with beta-alanine for 28 days female masters
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athletes elicited no significant reductions in body fat. Similarly in another study by Kresta et al.
(2014) researchers looked at changes in body weight, fat mass, fat free mass, and total body fat
and found that after supplementing with beta-alanine, creatine, or the combination for 28 days all
three groups had improvements in body weight and other markers of body composition over
time, but none were statistically significant. Kern et al. (2011) had in season wrestlers and
football players supplement with beta-alanine or placebo for 8 weeks and found that both groups
had increases in lean body mass. It should be noted that wrestlers during this phase of training
are also cutting weight, their losses in fat mass and weight were higher than those of the football
players who actually gained weight. While not significant, both groups increased lean mass as
compared to the placebo groups. Outlaw and colleagues (2012) found that after 8 weeks of both
supplementing with beta-alanine or placebo and undergoing a resistance training program that
both groups elicited improvements in lean body mass, fat mass, and total body fat %. While all
of these groups showed improvements or changes over time not all of them were statistically
significant and because most were already trained or were doing some sort of intervention we
cannot be sure that it was because of beta-alanine or the combination of exercise and BA
supplementation.
HIIT
Recurring bouts of very intense exercise with breaks that vary in length are referred to as sprint
interval training or high intensity interval training (HIIT). The physiological adaptations to this
type of training are similar to those of a more traditional endurance training protocol (longer
steady state exercise) and provide benefits such as: cardiopulmonary, metabolic, and
neuromuscular adaptations (National Strength & Conditioning Association, 2016). Moreover,
this type of workout is often appealing to individuals with time constraints, but is at a very high
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intensity and thus not appropriate for an untrained individual because of the dangers associated
with high intensities. In addition, the intensities and durations for work to rest ratios are
important factors to consider when dealing with different populations. In a review article,
Laursen et al. (2010) discusses the energy contributions made from both the anaerobic and
aerobic systems and how HIIT and high volume training can both elicit improvements in
exercise performance and should both be utilized. Bishop et al. (2004) investigated the
relationship between muscle buffer capacity and repeated sprint ability (RSA) among untrained
females. Results showed that VO2 peak and lactate threshold are significant predictors of RSA
and the ability to buffer H+ is important when one is trying to maintain performance during
repeated sprints. While this study did not implement a HIIT intervention, it did provide evidence
that training status and aerobic capacity of an individual can affect their ability to perform
repeated sprints. HIIT can provide anaerobic and aerobic enhancements, similar to a more
traditional endurance training program. Furthermore, it can increase muscle buffering capacity.
Burgomaster et al. (2005) aimed to examine the effects of short term (2 weeks) sprintinterval training (SIT) on endurance capacity at 80% of VO2 peak, maximal oxygen uptake, and
endurance time to exhaustion cycling. Results showed that there were no changes in VO2 peak,
but that aerobic endurance capacity improved by almost 100% in the SIT group as compared to
the control group. In another study done by Burgomaster and colleagues (2006), researchers
found similar results: there were no changes in VO2 peak, time trial cycling improved by ~10%
in the intervention group while also showing an increase in peak power output. This is in
contrast to what Talanian and colleagues (2006) found. Their study aimed to determine if two
weeks of high-intensity interval training (HIIT) had an effect on skeletal muscle metabolism,
aerobic capacity, and fat oxidation. Results showed that VO2 peak increased by 13% and whole
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body fat oxidation increased by 36%. Overall, even over a short period of time HIIT could
induce marked increases in time trial performance, VO2 peak, and endurance capacity.
Esfarjani and Laursen (2007) examined the difference between two different HIIT
protocols over 10 weeks on VO2 max, lactate threshold and 3,000 meter running performance.
Both groups had significant improvements in 3,000 meter run time, VO2 max, and lactate
threshold as compared to the control group.
Acka and Aras (2015) looked at differences between HIIT and supramaximal interval
training (SMIT) over 4 weeks on indoor rowing performance. The HIIT group was working at
90% of their PPO while the SMIT was working at 150% during each session. Both groups,
while not significantly different improved 2,000 meter rowing time, peak power output, and VO2
peak. These are similar findings to those of Driller et al. (2009) who also looked at the effects of
HIIT in well trained rowers. The HIIT group had significant improvements in 2,000 m time,
peak power, and relative VO2 peak. Both of these studies show that even well trained rowers can
benefit from HIIT at varying high intensities and that it can be especially beneficial when
training for a 2,000 m race when you need the last bout of energy to finish strong.
Beta-alanine and HIIT
High-intensity exercise can result in diminished stores of the adenosine tri-phosphate
(ATP), phosphocreatine (PCr) and glycogenic substrates, and the accumulation of intracellular
metabolites (adenosine di-phosphate[ADP], inorganic phosphate [Pi], hydrogen ions [H+] and
magnesium [Mg+]), each of which has been implicated as a cause of muscular fatigue (Smith et
al., 2009). As mentioned previously the formation of H+ can result in a decrease in pH, most of
these protons that are formed during exercise are buffered by the sodium bicarbonate system
(HCO3-). However, during short bursts of intense exercise, such as HIIT, the physiochemical
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buffering will exceed what the HCO3 – system and use other intramuscular stores of phosphates
and peptides. Carnosine concentration is high in skeletal muscle and its pKa of 6.83 make it
more effective at sequestering protons than either HCO3 – (pKa 6.73) or Pi (pKa 7.2), this is
limited by the availability of beta-alanine. Smith and colleagues (2009) conducted a study to
evaluate the effects of beta-alanine supplementation combined with high-intensity interval
training (HIIT) on endurance performance and aerobic metabolism in recreationally active
college-aged men. Forty-six men were randomly assigned to either the placebo or beta-alanine
group and were tested for VO2 peak, time to exhaustion (TTE), ventilatory threshold (VT), and
total work done (TWD) at 110% of pre-training VO2 peak. The beta-alanine group showed
significant improvements in VO2 peak, TTE, and TWD after the first three weeks of training.
Supplementing with beta-alanine may further enhance HIIT, improve endurance capacity, and
lean body mass in recreationally active men along with the use of HIIT to induce aerobic
improvements.
Saunders and colleagues (2012b) had amateur male footballers supplement with either
beta-alanine or placebo for 12 weeks and were asked to perform the YoYo Intermittent Recovery
Test 2 (IR2) prior to supplementation and again after 12 weeks of supplementation. This test
evaluates an individual’s capacity to perform high-intensity exercise while simultaneously
stimulating both aerobic and anaerobic energy pathways (Saunders, 2012b). Researchers found
that the distance covered by the beta-alanine group was significantly higher than the placebo
group after 12 weeks of supplementation, delaying neuromuscular fatigue, most likely due to
increased carnosine content. In another study by Kern et al (2011) football players and wrestlers
were randomized and placed into either a placebo or beta-alanine group for 8 weeks. All players
maintained regular team workout, similar to a periodized HIIT program. The football players
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showed greater improvements than the wrestlers in a 300 yard shuttle run and a 90º flexed arm
hang, while neither were statistically significant both improved with the groups who
supplemented with beta-alanine as to the placebo group.
Walter and colleagues (2010) looked at cardiovascular fitness and body composition
changes among women after supplementing with placebo or beta-alanine for 8 weeks. Both
groups underwent a rigorous periodized HIIT protocol on the cycle ergometer 3 times a week for
8 weeks. Both the placebo and beta-alanine groups showed improvements in VO2 peak as
compared to the control group, ventilatory threshold improved in all 3 groups, but no
improvements other than body mass increases for all groups occurred over 8 weeks. This is
similar to what Smith et al. (2009b) found after having men supplement with beta-alanine or
placebo for 6 weeks. There were significant changes in VO2 peak, time to exhaustion, and total
work done in both groups, while the group that supplemented with beta-alanine had greater
improvements in all three during the second three weeks of training. There were also significant
improvements with ventilatory threshold, but the placebo group had larger improvements during
the second half of the study. The beta-alanine group also showed gains in lean body mass, which
is similar to what Kerns et al. (2011) found.
In another study done by Smith and colleagues (2009a), neuromuscular fatigue and
muscle function among men after supplementing with beta-alanine or placebo combined with
HIIT over 6 weeks was observed. The researchers in this study used an EMG to identify
neuromuscular fatigue by looking for increases in amplitude. Both groups’ significantly
increased neuromuscular fatigue and physiological functioning of lower body muscle tissue, it
would appear that supplementing with beta-alanine had no impact and most positive results were
due to the HIIT. Similarly Stout and colleagues (2007) measured physical working capacity at
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fatigue threshold and saw significant improvements in neuromuscular fatigue, but no HIIT was
prescribed. While both delayed the onset of neuromuscular fatigue their findings show that one
is because of HIIT and the other because of beta-alanine supplementation. Despite the
conflicting results from both studies, it could be due to the methodological differences, or sample
size.
The potential ergogenic effects of beta-alanine supplementation, across a wide range of
exercises, has been shown to delay the onset of neuromuscular fatigue, and improve PPO or
TWD, while HIIT seems to have more effects on maximal oxygen uptake and buffering capacity.
Moreover, when combined BA has been shown to enhance HIIT, improve time to exhaustion and
in some cases stimulate lean body mass.
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CHAPTER III
METHODOLOGY
Participants
Thirty four females between the ages of 18-35 from Georgia Southern University were
recruited to participate in the study (Mean ± SD for age, height [cm], and weight [kg] are
reported in (Table 1). The requirements were that each woman was moderately active (~150
minutes/weekly as recommended by American College of Sports Medicine). Participants who
were currently or had taken any sort of ergogenic supplement (i.e. creatine or beta-alanine) in the
last 12 weeks were excluded from the study. This was a randomized, double-blind, placebocontrolled study and participants were randomly placed in either the control group (C), the
placebo group (PLA), or the Beta-alanine group (BA). The BA and PLA were labeled (A or B)
and placed in identical containers by the company (Carnosyn® Natural Alternatives International
(NAI), San Marcos, CA, USA) so that the researchers and participants could not tell the
difference. Participants were then matched with two other females based off of height, weight,
and self-reported hours of physical activity weekly and then randomly placed in either group A,
B, or C so that there was an equal distribution and matched participants throughout the groups.
The CON group underwent the pre and post testing procedures only, while the PLA and BA
groups did the pre and post testing procedures, and a 4 week HIIT intervention on the rowing
ergometer. The participants were given an explanation of the procedures, risks, possible benefits
from the intervention and/or supplement, and then gave informed consent to participate in the
study. The Institutional Review Board of Georgia Southern University approved this study.
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Familiarization
This was done during the first week of the study and participants were randomly assigned
to the BA, PLA, or CON groups these were labeled as A, B, and C respectively. Participants
were then asked to sign the informed consent, and go over testing protocols as well as rowing
technique. Participants were asked to fill out a Par-Q+ health questionnaire before any testing
takes place, those not contraindicated by Par-Q+ could safely engage in VO2max testing and high
intensity interval training. The participants were then asked to watch a short video
demonstrating proper rowing technique (concept2.com/technique) to help reduce injury and
increase efficiency on the rowing ergometer. During the familiarization period participants also
demonstrated to researchers that they were using proper techniques and had proper foot
placement on the rowing ergometer. Foot placement and attachment was important for optimal
performance and the heels were positioned in the foot stretcher so that the strap crossed over the
ball of participant’s foot, this was consistent throughout all testing procedures on the rowing
ergometer. While there are two parts to the rowing stroke, the drive and the recovery, it is all
done in one continuous motion. Participants extended arms forward, body leaning towards the
flywheel, and knees bent, this was the catch. The drive began with participants straightening
their legs, which did the majority of the work while keeping their arms and shoulders relaxed.
After the legs were fully extended the rower used their core and back to swing back to the
vertical position. During the last part of the drive the participant pulled the handle of the rowing
ergometer with their arms and shoulders into the abdomen, the legs were straight and the body
was leaning slightly back. The recovery began by extending the arms forward and swinging the
body forward at the hips, this put the handle back in front of the knees to avoid any interference
between the knees and the hands as the seat moved forward. The last motion, the catch, is the
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exact same as the start position and the participants could begin their next drive in one
continuous motion. Participants were reminded that their body should never come to a complete
stop (Concept II Product Manual). Once the participants felt comfortable with the equipment
and protocols they began pre-testing procedures.
Pre and Post Testing
All three groups underwent all pre-testing protocols: anthropometric measurements, body
composition on the dual energy x-ray absorptiometry (DEXA) scanner, a VO2 max test on a
Concept II Rowing Ergometer (Model E, Type II, Concept2 Inc., Morrisville, VT, USA) and a
1,000 meter time trial. The three groups of women all came to the Human Performance Lab
during week 2 for all pre testing and during week 7 for post testing procedures. The first day
included anthropometric measurements, DEXA scan, and VO2 max testing and no less than 48
hours later they came back to the lab to complete the 1,000 m time trial on the rowing ergometer.
Participants were also asked to keep a food log using My Fitness Pal (MyFitnessPal, Inc.) for
two weekdays and one weekend and to share the information with the researchers to keep track
of macronutrients in the diet. On testing days, participants were also asked to consume a diet
that was similar or the same to be consistent and to maintain their normal dietary and physical
activity routines throughout the duration of the study. Participants came to the lab for their first
day of actual testing wearing athletic attire. Their mass (kg) and height were measured (cm)
using a stadiometer, waist and hips (cm) were measured with a spring loaded Gulick Measuring
Tape (Country Technology, Inc., Gays Mills, WI,USA) and were done prior to the DEXA scan
and exercise.
Participants then had a whole body scan done using (DEXA) to determine body
composition. All scans were performed and analyzed by a trained technician using the AIS
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whole-body DEXA protocol (Nana et al., 2012). Prior to testing the DEXA Scanner (Lunar
Prodigy Model; GE/Lunar Corp, Madison, WI, USA) was calibrated per manufacturers
guidelines using the GE Encore 12.30 Software and phantom. Participants were instructed to
wear metal free clothing and to remove all jewelry and other metal before the scan. Each
individual was centrally positioned on the scanner and feet were strapped together to maintain a
constant distance (~15 cm), hands were placed at the sides within the given parameters. The
scan took about 6-8 minutes and the whole body scan mode was used. Researchers looked at
regional body fat % for both arms, legs, and trunk researchers had to manually adjust the regions
of interest (ROI). Stults-Kolehmainen et al. (2013) defined the regions of interest using the
following for parameters. The arm region was comprised of the arm and shoulder area formed
by placing a line from the crease of the axilla and through the glenohumeral joint. The trunk
region included the neck, chest, abdominal and pelvic areas. Its upper perimeter is the inferior
edge of the chin and the lower borders intersect the middle of the femoral necks without touching
the brim of the pelvis. The leg region included all of the area below the lines that formed the
lower borders of the trunk (Stults-Kolehmainen et al., 2013).
TheVO2max testing protocol was completed on the rowing ergometer using the
ParvoMedics Metabolic cart (True One 2400, Sandy, UT, USA). Prior to testing the metabolic
cart was calibrated per manufacturer’s guidelines, this included the gas and flowmeter calibration
protocols. Participants were then setup on the rowing ergometer (Model E, Concept2 Inc.,
Morrisville, VT, USA) and a heart rate monitoring strap was placed across the chest (Garmin
Model FR70, Olathe, KS, USA). The drag factor was set at 3 for all testing and intervention
days. The test began at an initial workload of 75 W for two minutes, and was then increased to
100 W for a further two minutes. The workload was then increased an additional 25 W every
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two minutes until the participant could no longer continue, despite verbal encouragement. If the
participants could not maintain appropriate Watts (within 15 above or below), or any
contraindications to testing arose, the test was terminated. All data was averaged over 15-s
intervals and the highest 15-s VO2 value during the graded exercise test was recorded as VO2peak ,
if it coincided with at least two of the following criteria: (a) a plateau in heart rate or heart rate
values within 10% of the age-predicted maximum heart rate, (b) a plateau in VO2 (defined by an
increase of no more than 150mL/min (Thompson et al., 2010) or the respiratory exchange ratio
has exceeded (RER > 1.15). The ventilatory threshold (VT) inflection point was determined by
the True One program using the V-slope method. This eliminated the need for multiple
researchers to evaluate and confirm inflection points. Maximal oxygen uptake (VO2peak) in
(L/min and ml/kg/min), power output at the ventilatory threshold (VT), time-to-exhaustion
(TTE), maximal heart rate, ratings of perceived exertion (RPE), using a 6-20 numeric scale
(Borg, 1970) were measured and recorded.
Within 48-72 hours of maximal testing participants came back to the Human
Performance Lab to complete an all-out 1,000 m time trial (TT) on the rowing ergometer.
Participants were set up on the Type II Concept Rower in the same fashion that they were on day
1 of pre-testing and a heart rate strap (Garmin Model FR70, Olathe, KS, USA or Polar) was
placed across the chest to monitor heart rate. Participants were allowed to warm up for 3-5
minutes at a low intensity before the TT and also allowed a cool down after the TT on the rowing
ergometer or treadmill. The distance was programmed into the PM4 monitor and display so that
the participant and researcher could see total distance covered, time, heart rate, average watts,
and peak power; these values were all recorded. Participants were informed to row “all out” and
told to not stop, encouragement was given throughout the test.
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Beta-alanine and Placebo Dosing
After being randomly assigned to either the beta-alanine (BA) or placebo (PLA) group,
which were called A and B respectively, participants were given weekly doses (56 pills) of
supplement or placebo in identical white bottles labeled A or B. Both groups took either 6.4
grams of maltodextrin or beta-alanine daily, these were the time-released capsules that were prepackaged and blinded by the company Carnosyn® (Natural Alternatives International, San
Marcos, CA, USA). Each participant took 2 pills four times daily (8 pills total) for 28 days, they
were given a log to keep track of times and doses on a weekly basis to ensure compliance. On
training days the participants were asked to consume one dose of their supplement or placebo 30
minutes prior to training and another immediately following. It was expected to observe an
increase in muscle carnosine content to be close to 15 mmol/kg dry muscle (an increase of 65%
in a participant eating a mixed diet), given that Harris et al. (2006) reported this level of increase
following a similar but slightly lower total dose of beta-alanine.
High Intensity Interval Training Protocol
During the next four weeks the PLA and BA groups met with a researcher to begin the
high intensity interval training intervention. Participants came to the Human Performance Lab
three times weekly on nonconsecutive days. Each session lasted around 15 minutes, participants
were asked to maintain a regular workout regimen during the week, but to refrain from workouts
on intervention days. These included a warm up and cool down on the rowing ergometer.
During the intervention portion of the study, PLA and BA groups were given training and
supplement logs to document their type, intensity, and duration of workouts along with their
dosing logs to ensure compliance. The intensities were undulating (Figure 1) and were based off
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of a similar protocol that Walter et al. (2012) did in their study on a similar population of
females. Thirty minutes prior to arriving, participants were asked to take two 800 mg capsules of
placebo or beta-alanine and take a second dose immediately following the training session.
Participants were setup on the rowing ergometer in the same fashion that they were in the
fatiguing and TT protocol; heart rate was monitored using a Garmin strap attached at the chest
(Garmin Model FR70, Olathe, KS, USA). The workout included a 5 minute warm-up and cool
down that was on the rowing ergometer. Participants warmed up at 75 W for 5 minutes followed
by 7 sets of 1-minute exercise bouts at a predetermined percentage of their peak workload using
a fractal periodization scheme (Walter et al., 2010). Peak workload was determined during the
TT testing and was reported as peak power output (PPO), this varied between participants and
was what determined their workload during training days. On all odd days (1, 3, 5, 7, 9, and 11)
participants rowed at a workload that was 90% of their predetermined PPO and on the even days
(2, 4, 6, 8, 10, and 12) the workload increased by 5% (95%, 100%, 105%, 110%, 110%, and
115%). Training volume (seconds completed at each interval), average Watts, heart rate, and
RPE were recorded. One minute of passive recovery was allowed between each set. At the end
of the 4 weeks, participants discontinued the placebo or beta-alanine supplementation and
followed up the next week for post testing procedures. Post–testing procedures followed the
exact same setup as the pre-testing procedures. The CON group also reported back to the lab for
post testing procedures.
Statistical Analyses
Eight separate 2 (time) [pre vs. post] ×3 (treatment) [BA vs. PLA vs. CON] repeated mixed
factorial analyses of variance (ANOVAs) were used to evaluate the following variables: relative
VO2 peak (ml/kg/min), ventilatory threshold (VT), time to complete 1,000 m time trial (TT),
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peak power output (PPO), total body fat percentage (BF %), body fat of arms (ABF %), body fat
of legs (LBF %), and trunk body fat (TBF %). Further one-way ANOVA’s were run when there
was a significant interaction between groups and time. The alpha level was set at p ≤ 0.05 to
determine statistical significance and a Bonferroni correction was applied. Data was analyzed
using SPSS for Windows version 21 (SPSS Inc., Chicago, IL, USA). All values are reported as
mean ± standard deviation (SD).
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CHAPTER IV
RESULTS
Subject Characteristics
A total of 21 of the 34 woman completed the entire study (BA = 8, PLA = 7, and CON = 6), five
dropped out due to injuries unrelated to the study, one became pregnant, and seven just did not
complete the study due to time constraints. The mean ± SD age for all participants (n = 21) was
22.2 ± 2.20, body mass 63.00 ± 8.52 (kg), and height 163.59 ± 6.69 (cm), and further subject
characteristics are shown in (Table 1).
Relative VO2 Peak (ml/kg/min)
Relative VO2 peak scores are shown in (Table 2). There was a main effect of time F (1, 18) =
15.07, p = 0.01,  2 = 0.46; the mean ± SD for all 3 groups was (35.84 ± 4.12 v. 39.24 ± 5.26) pre
and post testing. There was no significant interaction between groups and time F (2, 18) = 3.16,
p = 0.06,  2 =0.26 however it should be noted that the observed power was 0.53. There was no
difference between groups F (2, 18) = 0.77, p = 0.48.
Absolute VO2 Peak (l/min)
There was a main effect for time F (1, 18) = 22.60, p = 0.00,  2 =0.56; the mean ± SD for all 3
groups was (2.25 ± 0.39 v. 2.44 ± .045) pre and post testing. There was a significant interaction
by group and time F (2, 18) = 3.76, p = 0.04,  2 =0.30, further one way ANOVA’s were run on
all groups for the pre and post testing values. Post hoc analysis for pre testing values showed
nothing significant F (2, 18) = 1.42, p = 0.27. Further analysis for post testing values between
groups also showed no significance F (2, 18) = 2.74, p = 0.09.
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Time to Exhaustion TTE (seconds)
Time to exhaustion scores are shown in (Table 2). There was a main effect for time F (1, 18) =
13.15, p = 0.00,  2 =0.42; the mean ± SD for all 3 groups was (468.38 ± 98.34 v. 524.67 ±
99.89) pre and post testing. There were significant interactions by group and time F (2, 18) =
6.10, p = 0.01,  2 =0.40, observed power was 0.83, further ANOVA’s were run for the pre and
post testing values. Post hoc results for the pre testing values were not significant F (2, 18) =
0.55, p = 0.59. Further analysis for post testing values were also not significant F (2, 18) = 1.61,
p = 0.23.
Ventilatory Threshold % of VO2 Peak (VT)
Ventilatory threshold % data is shown in (Table 2). There was a main effect of time F (1, 18) =
6.01, p = 0.03,  2 =0.23; the mean ± SD for all 3 groups was (53.38 ± 11.46 v. 63.95 ± 7.26).
There were no significant interactions between groups and time F (2, 18) = 0.12, p = 0.74,  2
=0.03. There was also no significance between groups F (2, 18) = 0.14, p = 0.35.
Ventilatory Threshold (l/min)
There was a main effect of time F (1, 18) = 6.01, p = 0.03,  2 =0.25; the mean ± SD for all 3
groups was (1.34 ± 0.31 v. 1.54 ± 0.25 l/min). There were no significant interactions between
groups and time F (2, 18) = 0.12, p = 0.89,  2 =0.01 There was also no significance between
groups F (2, 18) = 1.11, p = 0.11,  2 =0.11.
Time Trial (TT)
Time trial data is shown in (Table 2). There was a main effect of time F (1. 18) = 27.38, p =
0.00,  2 =0.60; the mean ± SD for all groups was (266.71 ± 19.08 v. 261.83 ± 14.55) seconds.
There was an interaction between groups and time F (2, 18) = 5.17, p = 0.02,  2 =0.37, observed
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power = 0.76, further one-way ANOVA’s were run for the pre and post testing values. Post hoc
results showed that there was not significance between groups in the pre-testing F (2, 18) = 0.65,
p = 0.53. Further analysis between the groups for the post testing showed no significance F (2,
18) = 0.85, p = 0.44.
Peak Power Output (PPO)
PPO data is shown in (Table 2). There was a main effect of time F (1, 18) = 60.65, p = 0.00,  2
=0.77; the mean ± SD for all groups was (244.86 ± 42.15 v. 322.81 ± 68.21 W) measured in
Watts. There was an interaction between groups and time F (2, 18) = 14.07, p = 0.00,  2 =0.61,
observed power = 0.10, further one-way ANOVA’s were run on the pre and post testing values.
The pre-testing post hoc showed no statistical significance between groups F (2, 18) = 0.05, p =
0.95. Post testing results (Figure 2) revealed significance between groups BA (325.13 ± 22.611
W) and CON (254.00 ± 40.60 W) groups, p = 0.05 and PLA (378.71 ± 72.23 W) and CON
groups, p = 0.00.
Total Body Fat % (BF)
Total body fat % scores are shown in (Table 3). There was no main effect of time F (1, 18) =
2.64, p = 0.12,  2 =0.13; the mean ± SD for all groups was (31.10 ± 5.71 v. 30.71 5.50) percent
body fat. There were significant interactions between groups over time F (2, 18) = 4.71, p =
0.02,  2 =0.34, observed power = 0.72. Further one-way ANOVA’s were run on pre and post
testing values. The post hoc testing for the pre testing values did not show any significance F (2,
18) = 0.91, p = 0.42. The post testing values also showed no significance F (2, 18) = 1.26, p =
0.31.
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Body Fat % of Arms (ABF)
Arm body fat % scores are shown in (Table 3). There was a main effect of time F (1, 18) =
10.42, p = 0.01,  2 =0.37; the mean ± SD for all groups was (27.07 ± 5.95 v. 25.95 ± 5.86)
percent body fat in the arms. There were no significant interactions between groups over time F
(2, 18) = 1.98, p = 0.17,  2 =0.18. There was also no significance between subjects F (2, 18) =
1.40, p = 0.27.
Body Fat % of Legs (LBF)
Leg body fat % scores are shown in (Table 3). There was no main effect of time F (1, 18) =
0.60, p = 0.45,  2 =0.03. There was a significant interaction over time between groups F (2, 18)
= 3.75, p = 0.04,  2 =0.30, observed power = 0.61. Further one way ANOVA’s were run on the
pre and post testing values. The pre testing values showed no significance between groups F (2,
18) = 0.77, p = 0.48. The post testing values also showed no significance F (2, 18) = 1.05, p =
0.37.
Body Fat % of Trunk (TBF)
Trunk body fat % scores are shown in (Table 3). There was no main effect of time F (1, 18) =
2.28, p = 0.15,  2 =0.11. There was a significant interaction between groups F (2, 18) = 5.28, p
= 0.01,  2 =0.42, observed power = 0.85. Further post hoc analysis for the pre testing values
showed no statistical significance F (2, 18) = 1.13, p = 0.35. Further post hoc testing also did not
show any significance F (2, 18) = 1.68, p = 0.21 in the post testing results.
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CHAPTER V
DISCUSSION
The purpose of this study was to determine if supplementing with beta-alanine combined
with four weeks of high intensity interval training on the rowing ergometer would elicit
improvements in VO2 peak, ventilatory threshold, peak power output, and body composition.
The secondary purpose was to look at time to complete a 1,000 meter rowing time trial and
changes in regional body fat. While there is a growing body of evidence that indicates positive
effects of beta-alanine supplementation on performance measures, several studies have found no
notable impact. This study suggests, however, that supplementation with beta-alanine combined
with HIIT can attenuate fatigue and increase peak power output during time trial performance.
The main finding of this study indicates that over time both the placebo and beta-alanine groups
showed improvements in VO2 peak, time to exhaustion, ventilatory threshold, peak power
output, and reduced arm body fat percentage. The most noteworthy finding was that the placebo
and beta-alanine groups had significant improvements in peak power post testing compared with
the control group. This was the only variable measured that revealed any changes between
groups and was likely due to the HIIT intervention.
VO2 peak in both the BA and PLA groups improved over time as compared to the CON
group, however there was no significant difference between those two groups. These results are
comparable with what several other studies found (Smith et al., 2012; Smith et al.2009b;
Walteret et al., 2010), all of which saw improvements in VO2 peak and TTE. Both Walter et al.
(2010) and Smith et al. (2009b) implemented a HIIT protocol for six weeks combined with the
beta-alanine supplementation. In contrast, a number of other studies have found that
supplementing with beta-alanine (or combining another nutritional supplement, e.g. creatine or
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sodium bicarbonate) and/or implementing HIIT has not shown improvements in VO2 peak or
TTE (Jordan et al., 2010; Zoeller et el., 2007; Outlaw et el., 2014; Baguet et el., 2010b, Stout et
el., 2006). Jordan et al. (2010) showed decrements in maximal oxygen uptake, but delays in the
onset of blood lactate accumulation (OBLA) in the BA group, which could suggest that
increases in carnosine can attenuate fatigue. Similarly, Zoeller and colleagues (2007) noted
increases in power output at lactate threshold, while the VO2 remained unchanged; neither of
these studies had an exercise intervention along with supplementation. Outlaw et al. (2014)
looked at the combination of resistance training and beta-alanine supplementation over 8 weeks
and showed no improvements in VO2 peak or TTE, but the researchers did suggest that it might
lead to increased muscular endurance. Moreover, several studies have found aerobic and
anaerobic benefits after short and long term HIIT (Driller et al., 2009; Acka and Aras, 2015;
Esfarjani et al., 2006). Both Acka and Aras (2015) and Driller et al. (2009) looked at varying
intensities of high intensity training among elite rowers as compared to a more conventional
rowing training regimen and found that all groups improved VO2 as compared to control group.
The results of our study showed VO2 peak improvements in both the BA and PLA groups
over time as compared to the CON group, commensurate with what other researchers found
using similar protocols. In reviewing the literature it should be noted that the studies that did see
improvements in aerobic capacity typically used a HIIT protocol, while BA supplementation
alone did not substantiate any improvements in VO2 peak. Therefore, we can postulate that the
improvements seen were most likely due to the HIIT protocol and training adaptations that
occurred on the rowing ergometer and not from BA supplementation. In addition, our data
showed that both the BA and PLA groups improved VT as % of VO2 and VT (l/min) over time,
but there were no differences between groups. These results support what other studies found
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(Stout et al., 2006; Zoeller et al., 2007; Walter et al., 2010). Stout et al. (2006) indicated that
supplementing with beta-alanine can elicit improvements in VT (l/min) and physical working
capacity at fatigue threshold (PWCFT), therefore delaying neuromuscular fatigue. Some studies
have looked at BA supplementation combined with HIIT and found improvements in VT, total
work done (TWD), and power output at VT (Smith et al., 2009b; Walter et al., 2010). In contrast
Smith and colleagues (2012) found no differences in ventilatory threshold over time or between
groups who supplemented with BA or PLA and did not receive any sort of exercise intervention.
The improvements of VT, PWCFT, and TTE might have been due to increases in carnosine
concentration through beta-alanine supplementation. These results might suggest that
supplementing with beta-alanine can help maintain intramuscular pH during intense exercises
when accumulation of H+ ions is high and delay the onset of neuromuscular fatigue. These
muscle carnosine increases must be assumed because carnosine was not directly measured in the
current study.
Participants were asked to do an all-out 1,000 m row during the pre and post testing to
determine total time and peak power output. While there were no changes over time in any of
the groups for completion time there were for peak power out (PPO). There were also
differences between groups for TT and PPO. While further testing between groups during pre
and post testing for TT did not reveal any significant differences, our data supports the
hypothesis that both the BA and PLA groups would significantly improve their PPO as compared
to the CON group. However, another hypothesis was that the BA group would be significantly
higher than the PLA group, yet there were no differences. There have been a few studies that
have examined 2,000 m time trial performance among elite rowers (Ducker et al., 2013; Baguet,
2010) while supplementing with beta-alanine and maintaining their typical training. Both studies
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found no significant improvements in TT performance after supplementation with BA; however,
it should be noted that while these were not significant there were reductions in overall time to
complete a 2,000 m TT. In a competition setting this would be considered a considerable
difference. This was similar to what Kern and Robinson (2011) found among football players in
season; their 300 m shuttle time improved (1.1 seconds) after supplementing with BA as
compared to PLA group (0.4 seconds). While Ducker et al. (2013) did not see improvements in
TT after 28 days of beta-alanine supplementation split times and average power did increase in
the BA group as compared to the PLA group. In a comparable study Baguet and colleagues
(2010) determined that there was a positive correlation between increased carnosine content and
rowing performance. Similarly Saunders et al. (2012a) and Derave et al. (2007) found no
improvements in performance after supplementing with beta-alanine. While these studies had
methodological differences and did not look at a time trial specifically they did look at distance
covered during LIST (repeated sprints) and time to complete a 400 m run respectively. In
contrast Saunders and colleagues (2012b) found that football players (soccer) significantly
increased distance covered during the anaerobic YoYo IR2 (see definition) after supplementing
with BA for 12 weeks.
There are a multitude of studies using a variety of modes that found improvements in
time trial performance after implementing a HIIT program anywhere from 2-8 weeks long with
varying degrees of intensities (Acka and Aras, 2015; Driller et al., 2009; Burgomaster et al.,
2005; Esfarjani et al., 2007). Driller et al. (2009) and Acka and Aras (2015) both looked at
performance among elite rowers after having groups either use a more conventional training
method for rowing or HIIT; both groups 2,000 m time and average power significantly improved
during the TT. Burgomaster et al. (2005) and Esfarjani et al. (2007) used the cycle ergometer
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and running respectively and implemented varying intensities for the HIIT protocol; both saw
significant improvements in time. In a meta-analysis, Hobson et al. (2012) concluded that BA
was effective in improving high intensity exercise in durations between 60-240 seconds and in
excess of 240 seconds and that the anaerobic energy system contributed significantly. The
current study might not have had a large enough sample to determine if the BA was as much of a
contribution to performance enhancements as the HIIT.
Results indicated that PPO improved over time and that there were significant differences
between the BA and CON and the PLA and CON. In addition, it appears that the increases in
PPO were due more to the HIIT rather than the combination of HIIT and BA supplementation
which could also be a reflection of low sample size. Several other studies have shown that betaalanine supplementation alone can elicit improvements in PPO (Tobias et al., 2013; Ducker et
al., 2013; Van Thienen et al., 2009; Painelli et el., 2014). Researchers that implemented HIIT on
a variety of modes supported these findings (Acka and Aras, 2015; Driller et al., 2015;
Burgomaster et al., 2005). Smith and colleagues (2009b) found that TWD improved after
supplementing with BA combined with HIIT over 6 weeks. In contrast the study by Outlaw et
al. (2014) did not show any significant improvements in PPO after 8 weeks of BA
supplementation combined with a resistance training program. Other studies suggest that the
combination of BA and HIIT can further delay time to exhaustion and improve TWD or PPO.
One can speculate that the current study might have found differences between the BA and PLA
groups had more women been recruited and perhaps matched based on VO2 peak or PPO from
the initial pre-testing procedures.
This study did not show any significant differences in total BF%, leg BF%, or trunk BF%
over time or between groups. While most studies using DEXA looked only at total body fat
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percentage (BF%), lean body mass, and fat mass, our study assessed all of these as well as
regional areas of interest (arms, legs, and trunk), similar to (Glenn et al., 2015), which showed
comparable results to the current study. A number of other studies have looked at the ergogenic
effects of beta-alanine supplementation on body composition and found similar results (Kresta et
al., 2014; Kern et al., 2011; Outlaw et al., 2014; Walter et al., 2010). While these studies had
methodological differences they all indicated that BF%, fat mass, and fat free mass improved
over time for both the PLA and BA groups. It should be noted that all of the aforementioned
studies also included some sort of training intervention along with supplementation of BA.
Interestingly, Walter et al. (2010) also indicated that the BA group had significant body mass
increases, although researchers were unclear as to why. According to Nana et al. (2012) any
subjects that are undergoing a whole-body scan, using DEXA, must be in a rested, fasted, and
euhydrated state. In the current study, participants were asked to come to the lab well hydrated
and to have had some sort of breakfast, because they were engaging in volitional fatigue testing
and needed to be well hydrated. One possible limitation of the study was that participants did not
eat consistent meals on those days and could have been in a different state of hydration, which
could cause variability in the results. Contrary to expectations, the data indicated that the regions
of interest (legs, arms, or trunk) showed no significant findings between groups or over time.
Because of the time of year, time commitment, and difficulty of the HIIT protocol this
study had very low recruitment. Further, the small sample size of the present study resulted in
low statistical power and increased the risk of type II errors and may have contributed to the lack
of significant findings that research has demonstrated. Participants were not evenly matched
between groups, in part some participants quit the study, which caused the groups to become
unevenly balanced. As neither menstrual cycles nor hormonal changes were not accounted for in
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the present study, future studies could time training around certain phases of the menstrual cycle
for more accuracy.
Conclusions
To the best of our knowledge, this is one the first studies that utilized the rowing
ergometer as a mode for non-elite rowers, and one of few that used recreationally active females.
Although there were improvements in performance, it cannot be concluded that supplementing
with beta-alanine combined with HIIT provides enhancements. This study determined that HIIT
had a significant impact on exercise performance, while the results did not show much from the
additional BA supplementation. Moreover, supplementation with beta-alanine may have more
impact on exercise capacity (TTE, PPO) while HIIT can offer improvements in aerobic and
anaerobic performance. Furthermore, the results of the present study did not reveal any
significant changes in body composition. The lack of significance in this study may have been
due to how we participants were matched and low sample size. Future researchers should
consider using a 3 or 4-c model to analyze body composition to take multiple factors into
account and have participants come to the lab in a fasted and euhydrated state on a day when no
other testing is taking place. Additionally, a cross-over design would be preferred so that
participants would receive the same treatments and matching would not be an issue. Such a
design is very time consuming and would require prolonged washout periods of at least 12
weeks. Future studies should also consider matching subjects based off of peak power, VO2
peak, or total work done. Although changes in muscle carnosine were not measured in this
study, the dosing protocol was comparable to other studies (Harris et al., 2006) that showed a
~60% increase in carnosine levels after 4 weeks of supplementation. Given that beta-alanine is
rate limiting pre-cursor for carnosine synthesis, it can be assumed that supplementing with this

43

ergogenic aid will elevate muscle carnosine content. Ideally, future studies would measure
carnosine content and blood lactate, as it could provide valuable data. Finally, food diaries and
compliance are complicating factors, as they are incredibly difficult to monitor because of
honesty and memory recall. Additionally, future studies might want to use the rowing ergometer
as a mode for recreationally active males or females as it can provide a whole body workout and
consider using combined supplementation (beta-alanine, creatine, or sodium bicarbonate).
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APPENDIX A
Research Questions
1. Was there a combined effect from BA supplementation and HIIT on VO2 peak, TTE,and
body composition?
2. Did supplementation with BA combined with HIIT on the rowing ergometer elicit
changes in regional areas of interest (arms, trunk, or legs)?
3. Will the combination of HIIT and BA supplementation reduce the time to complete a
1,000 m time trial and increase peak power output?
Assumptions
1. That all participants will comply with dosing protocols.
2. That all participants will accurately document their physical activity and food diaries.
3. That all participants gave 100% during all pre and post testing procedures and during the
training protocol.
Limitations
1. Only using women 18-35
2. Did not control for menstrual cycles or hormonal changes
3. Cannot control diet or exercise outside of the lab setting
4. Compliance with placebo and beta-alanine supplementation
Definitions
1. ATP-PC System: metabolic pathway that uses ATP and phosphocreatine to
rephosphorylate ADP. It is used at the initial onset of exercise and during high intensity
exercise.
2. ADP (adenosine diphosphate): a molecule that combines with inorganic phosphate to
form ATP.
3. ATP (Adenosine triphosphate): high energy phosphate used by cells to release energy
during work.
4. H+ (Hydrogen Ions): free hydrogen ion in a solution that can result in a decrease in pH.
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5. LIST Test (Loughborough Intermittent Sprint Testing): variable-intensity shuttle
running over 20 m, mimics the characteristics of a soccer game.
6. pKa: an index used to express the acidity of weak acids.
7. YoYoIR2: test to evaluate ability of an individual to repeatedly perform and recover
form intense exercise, while stimulating both the aerobic and anaerobic energy systems.
8. DEXA (Dual energy-ray absorptiometry): a tool normally used to assess bone mineral
content, but has been recently used to assess body composition using a three
compartment model (fat mass, fat free mass, and bone mineral content). Moreover, it can
also assess whole body and regional estimates of fat %.
9. BOD POD: Gold standard device used for body composition measurement. It uses air
displacement plethysmography and whole body densitometry to determine body
composition (fat and fat free mass).
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PAR-Q+
The Physical Activity Readiness Questionnaire for E v e r y o n e
Regular physical activity is fun and healthy, and more people should become more physically active every day of the week.
Being
more physically active is very safe for MOST people. This questionnaire will tell you whether it is necessary for you to
seek further
advice from your doctor OR a qualified exercise professional before becoming more physically active.

SECTION 1 - GENERAL HEALTH
Please read the 7 questions below carefully and answer each one honestly: check YES or NO.

YES

NO





Do you feel pain in your chest at rest, during your daily activities of living, OR when you do physical
activity?





Do you lose balance because of dizziness OR have you lost consciousness in the last 12 months?
Please answer NO if your dizziness was associated with over-breathing (including during vigorous
exercise).
Have you ever been diagnosed with another chronic medical









5. Are you currently taking prescribed medications for a chronic medical condition?





Do you have a bone or joint problem that could be made worse by becoming more physically active?
6. Please answer NO if you had a joint problem in the past, but it does not limit your current ability to be
physically active. For example, knee, ankle, shoulder or other.





7. Has your doctor ever said that you should only do medically supervised physical activity?





1. Has your doctor ever said that you have a heart condition OR high blood pressure?
2.
3.
4.

condition (other than heart disease or high blood pressure)?

If you answered NO to all of the questions above, you are cleared for physical activity.
Go to Section 3 to sign the form. You do not need to complete Section 2.





!

›
›
›
›

Start becoming much more physically active – start slowly and build up gradually.
Follow the Canadian Physical Activity Guidelines for your age (www.csep.ca/guidelines).
You may take part in a health and fitness appraisal.
If you have any further questions, contact a qualified exercise professional such as a
CSEP Certified Exercise Physiologist® (CSEP-CEP) or CSEP Certified Personal Trainer®
(CSEP-CPT).
› If you are over the age of 45 yrs. and NOT accustomed to regular vigorous physical activity,
please consult a qualified exercise professional (CSEP-CEP) before engaging in maximal effort
exercise.
If you answered YES to one or more of the questions above, please GO TO SECTION 2 .
Delay becoming more active if:
› You are not feeling well because of a temporary illness such as a cold or fever – wait until you
feel better
› You are pregnant – talk to your health care practitioner, your physician, a qualified exercise
professional, and/or complete the PAR med-X for Pregnancy before becoming more physically
active OR
› Your health changes – please answer the questions on Section 2 of this document and/or talk to
your doctor or qualified exercise professional (CSEP-CEP or CSEP-CPT) before continuing with
any physical activity program.

SECTION 2 - CHRONIC MEDICAL CONDITIONS
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Please read the questions below carefully and answer each one honestly: check YES or NO.

YES


1. Do you have Arthritis, Osteoporosis, or Back Problems?
Do you have difficulty controlling your condition with medications or other
1a. physician-prescribed therapies? (Answer NO if you are not currently taking
medications or other treatments)
Do you have joint problems causing pain, a recent fracture or fracture caused
by osteoporosis or cancer, displaced vertebra (e.g., spondylolisthesis), and/
1b.
or spondylolysis/pars defect (a crack in the bony ring on the back of the spinal
column)?
Have you had steroid injections or taken steroid tablets regularly for more than 3
1c.
months?

If yes, answer
questions
1a-1c

2a.

Does your cancer diagnosis include any of the following types: lung/bronchogenic,
multiple myeloma (cancer of plasma cells), head, and neck?

2b. Are you currently receiving cancer therapy (such as chemotherapy or radiotherapy)?


If no, go to
question 2














2. Do you have Cancer of any kind?

NO

If yes, answer
questions
2a-2b


If no, go to
question 3













If yes, answer
questions
3a-3e

If no, go to
question 4









3c. Do you have chronic heart failure?





Do you have a resting blood pressure equal to or greater than 160/90 mmHg with or
3d.
without medication? (Answer YES if you do not know your resting blood pressure)









Do you have Heart Disease or Cardiovascular Disease?
3. This includes Coronary Artery Disease, High Blood Pressure, Heart Failure, Diagnosed
Abnormality of Heart Rhythm
Do you have difficulty controlling your condition with medications or other
3a. physician-prescribed therapies?
(Answer NO if you are not currently taking medications or other treatments)
Do you have an irregular heart beat that requires medical management?
3b.
(e.g. atrial fibrillation, premature ventricular contraction)

3e.

Do you have diagnosed coronary artery (cardiovascular) disease and have not
participated in regular physical activity in the last 2 months?

4. Do you have any Metabolic Conditions?
This includes Type 1 Diabetes, Type 2 Diabetes, Pre-Diabetes
4a. Is your blood sugar often above 13.0 mmol/L? (Answer YES if you are not sure)
Do you have any signs or symptoms of diabetes complications such as heart
4b. or vascular disease and/or complications affecting your eyes, kidneys, and the
sensation in your toes and feet?
Do you have other metabolic conditions (such as thyroid disorders, pregnancy4c.
related diabetes, chronic kidney disease, liver problems)?
Do you have any Mental Health Problems or Learning Difficulties?
5. This includes Alzheimer’s, Dementia, Depression, Anxiety Disorder, Eating Disorder,
Psychotic Disorder, Intellectual Disability, Down Syndrome)


If yes, answer
questions
4a-4c


If no, go to
question 5














If yes, answer
questions
5a-5b


If no, go to
question 6

Do you have difficulty controlling your condition with medications or other
5a. physician-prescribed therapies? (Answer NO if you are not currently taking
medications or other treatments)





5b. Do you also have back problems affecting nerves or muscles?
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Please read the questions below carefully and answer each one honestly: check YES or NO.
Do you have a Respiratory Disease?
6. This includes Chronic Obstructive Pulmonary Disease, Asthma, Pulmonary High
Blood Pressure
Do you have difficulty controlling your condition with medications or
6a. other physician-prescribed therapies?
(Answer NO if you are not currently taking medications or other treatments)

YES


If yes,
answer
questions
6a-6d

NO


If no, go to
question 7









If asthmatic, do you currently have symptoms of chest tightness, wheezing, labored
6c. breathing, consistent cough (more than 2 days/week), or have you used your rescue
medication more than twice in the last week?





Has your doctor ever said you have high blood pressure in the blood vessels of
your lungs?





6b.

6d.

Has your doctor ever said your blood oxygen level is low at rest or during
exercise and/or that you require supplemental oxygen therapy?


7. Do you have a Spinal Cord Injury? This includes Tetraplegia and Paraplegia

Do you have difficulty controlling your condition with medications or
7a. other physician-prescribed therapies?
(Answer NO if you are not currently taking medications or other treatments)

If yes,
answer
questions
7a-7c


If no, go to
question 8





7b.

Do you commonly exhibit low resting blood pressure significant enough to
cause dizziness, light-headedness, and/or fainting?





7c.

Has your physician indicated that you exhibit sudden bouts of high blood
pressure (known as Autonomic Dysreflexia)?





8. Have you had a Stroke?
This includes Transient Ischemic Attack (TIA) or Cerebrovascular Event
Do you have difficulty controlling your condition with medications or
8a. other physician-prescribed therapies?
(Answer NO if you are not currently taking medications or other treatments)


If yes,
answer
questions
8a-c

8b. Do you have any impairment in walking or mobility?
8c.

Have you experienced a stroke or impairment in nerves or muscles in the past 6
months?














9. Do you have any other medical condition not listed above or do you live with two
chronic conditions?
Have you experienced a blackout, fainted, or lost consciousness as a result of a head
9a. injury within the last 12 months OR have you had a diagnosed concussion within the
last 12 months?
9b.

If yes,
answer
questions
9a-c

Do you have a medical condition that is not listed
(such as epilepsy, neurological conditions, and kidney problems)?

9c. Do you currently live with two chronic conditions?

Please proceed to Page 4 for recommendations for your current medical condition and sign this document.


If no, go to
question 9


If no, read
the advice
on page 4
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PAR-Q+


If you answered NO to all of the follow-up questions about your medical condition, you are ready to
become more physically active:
› It is advised that you consult a qualified exercise professional (e.g., a CSEP-CEP or CSEP-CPT) to h e l p
you develop a safe and effective physical activity plan to meet your health needs.
› You are encouraged to start slowly and build up gradually – 20-60 min. of low- to moderate-intensity
exercise, 3-5 days per week including aerobic and muscle strengthening exercises.
› As you progress, you should aim to accumulate 150 minutes or more of moderate-intensity physical
activity per week.
› If you are over the age of 45 yrs. and NOT accustomed to regular vigorous physical activity, please
consult a qualified exercise professional (CSEP-CEP) before engaging in maximal effort exercise.



If you answered YES to one or more of the follow-up questions about your medical condition:
› You should seek further information from a licensed health care professional before becoming more
physically active or engaging in a fitness appraisal and/or visit a or qualified exercise professional
(CSEP-CEP) for further information.
Delay becoming more active if:
› You are not feeling well because of a temporary illness such as a cold or fever – wait until you feel better
› You are pregnant - talk to your health care practitioner, your physician, a qualified exercise professional,
and/or complete the PARmed-X for Pregnancy before becoming more physically active OR
› Your health changes - please talk to your doctor or qualified exercise professional (CSEP-CEP) before
continuing with any physical activity program.

SECTION 3 - DECLARATION
›
›

You are encouraged to photocopy the PAR-Q+. You must use the entire questionnaire and NO changes are permitted.
The Canadian Society for Exercise Physiology, the PAR-Q+ Collaboration, and their agents assume no liability for persons
who undertake physical activity. If in doubt after completing the questionnaire, consult your doctor prior to physical activity.

› If you are less than the legal age required for consent or require the assent of a care provider, your parent, guardian or care
provider must also sign this form.

›

Please read and sign the declaration below:
I, the undersigned, have read, understood to my full satisfaction and completed this questionnaire. I acknowledge that t his
physical activity clearance is valid for a maximum of 12 months from the date it is completed and becomes invalid
if my
condition changes. I also acknowledge that a Trustee (such as my employer, community/fitness center, health care
provider, or other designate) may retain a copy of this form for their records. In these instances, the Trustee will be requ ired
to adhere to local, national, and international guidelines regarding the storage of personal health information ensuring that
they maintain the privacy of the information and do not misuse or wrongfully disclose such information

NAME

SIGNATURE

SIGNATURE OF PARENT/GUARDI

DATE

WITNESS
The PAR-Q+ was created using the evidencebased AGREE process (1) by the PAR-Q
Collaboration chaired by Dr. Darren E.
R. Warburton with Dr. Norman Gledhill, Dr.
Veronica Jamnik, and Dr. Donald C. McKenzie (2).
Production of this document has been made
possible through financial contributions from the
Public Health Agency of Canada and the BC
Ministry of Health Services. The views expressed
herein do not necessarily represent the views of
the Public Health Agency of Canada or BC Ministry
of Health Services.
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APPENDIX C
TABLES & FIGURES

TABLE 1: Subject Characteristics

MEAN +/- STANDARD DEVIATION
GROUP

Age

HEIGHT
(cm)

MASS (kg)
PRE

MASS (kg)
POST

BA (n=8)

21.38 ± 2.33

162.01 ± 6.44

62.56 ± 8.43

61.43 ± 5.84

PLA (n=7)

23.86 ± 2.12

164.97 ± 7.46

66.67 ± 10.46

66.77 ± 10.09

CON
(n=6)

21.33 ± 0.82

164.08 ± 6.86

59.31 ± 4.9

59.32 ± 4.77

TOTAL
(n=21)

22.2 ± 2.2

163.69 ± 6.92

63 ± 8.52

62.61 ± 7.62
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TABLES
TABLE 2: Pre & Post Testing Results

Mean +/- Standard Deviation
GROUP

Relative
TTE (seconds)
VO2 peak
during VO2
(ml/kg/min)

VT as % of
VO2

TT (seconds)

PPO (Watts)

PRE

POST

PRE

POST

PRE

POST

PRE

POST

PRE

POST

BA (n=8)

34.49 ±
4.46

38.58 ±
3.06

441.25 ±
73.25

518.25 ±
80.29

58.13 ±
9.11

65.38 ±
6.70

272.88 ±
17.74

257.00 ±
14.46

241.25 ±
23.63

325.13 ±
22.61

PLA (n=7)

36.50 ±
3.48

41.83 ±
6.58

474.43 ±
135.41

573.86 ±
115.12

58.29 ±
10.48

61.29 ±
7.65

262.86 ±
23.90

249.14 ±
22.97

245.57 ±
53.58

378.71 ±
72.23

CON (n=6)

36.87 ±
4.54

37.10 ±
5.48

497.50 ±
83.21

477.00 ±
94.53

58.83 ±
16.63

65.17 ±
7.94

263.00 ±
15.24

261.82 ±
14.55

248.83 ±
53.28

254.50 ±
40.60

TOTAL
(n=21)

35.84 ±
4.12

39.24 ±
5.26 *

468.38 ±
98.34

524.67 ±
99.89 *

58.38 ±
11.46

63.95 ±
7.26 *

266.71 ±
19.08

255.76 ±
17.65 *

244.86 ±
42.15

322.81 ±
68.20 *

* Indicates that post testing values were significantly higher than the pre-testing values (p ≤ 0.05)
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TABLE 3: Body Composition Results

Body Composition Mean +/- Standard Deviation
GROUP

BA (n=8)
PLA (n=7)
CON (n=6)
TOTAL
(n=21)

Total BF %
PRE
33.25 +/6.53
29.83 +/5.48
29.70 +/4.78
31.10 +/- 5.71

POST
32.99 +/5.98
28.61 +/5.30
30.13 +/4.73
30.71 +/5.50

Arm BF %
PRE

POST

29.48 +/- 6.58

28.81 +/- 5.88

25.53 +/- 5.90

23.44 +/- 5.33

25.67 +/- 4.91

25.07 +/- 5.68

27.07 +/- 5.10

25.95 +/- 5.86 *

Trunk BF %
PRE
32.94 +/7.24
28.54 +/4.55
29.32 +/5.80
30.44 +/6.10

POST
32.43 +/6.64
26.89 +/4.96
30.22 +/5.68
29.95 +/6.05

* Indicates that post testing values were significantly higher than the pre-testing values (p ≤ 0.05)

Leg BF %
PRE
35.01 +/6.38
32.76 +/6.54
31.13 +/4.08
33.15 +/5.82

POST
35.24 +/6.02
31.70 +/6.23
31.43 +/4.03
32.97 +/5.63
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FIGURES
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Figure 1 Workload for periodized HIIT Protocol
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Figure 2 * (p ≤ 0.05). PPO was significantly higher during post testing for the BA and PLA
groups as compared to the CON group

